Page last updated: 2024-08-23

fagaronine and Leukemia P388

fagaronine has been researched along with Leukemia P388 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Comoe, L; Couprie, J; Desoize, B; Grondard, L; Jardillier, JC; Larsen, AK; Riou, JF1
Bisagni, E; Croisy, A; Janin, YL; Riou, JF1

Other Studies

2 other study(ies) available for fagaronine and Leukemia P388

ArticleYear
The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II.
    Biochemical pharmacology, 1993, Oct-19, Volume: 46, Issue:8

    Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Benzophenanthridines; Camptothecin; Catalysis; Cattle; Cricetinae; Cricetulus; DNA; DNA Topoisomerases, Type II; Drug Resistance; Fibrosarcoma; Intercalating Agents; Leukemia P388; Mice; Phenanthridines; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1993
Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives.
    Journal of medicinal chemistry, 1993, Nov-12, Volume: 36, Issue:23

    Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Benzophenanthridines; Breast Neoplasms; Humans; Leukemia L1210; Leukemia P388; Mice; Molecular Structure; Phenanthridines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1993